European Investment Co Llc Celgene serves as Executive at Epizyme, Inc., where they oversee executive responsibilities. Since joining the company, European Investment Co Llc Celgene has executed 5 insider transactions totaling $49.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 16, 2014 involved purchasing 228,645 shares valued at $25.3M.
European Investment Co Llc Celgene currently holds 1,231,778 shares of Epizyme, Inc. (EPZM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, European Investment Co Llc Celgene has been a net buyer of EPZM stock. They have purchased $49.2M and sold $0 worth of shares.
European Investment Co Llc Celgene's most recent insider trade was on Dec 16, 2014, when they purchased 228,645 shares at $110.75 per share.
Get notified when new Form 4 filings are submitted
| $44.00 |
| Discretionary |
| Feb 10, 2014 | EPZM | $9.9M | Purchase | 340,000 | $29.25 | Discretionary |
| Jun 5, 2013 | EPZM | $0 | Conversion | 3,267,974 | $N/A | Discretionary |
| Jun 5, 2013 | EPZM | $1000.0K | Purchase | 66,666 | $15.00 | Discretionary |